Fresenius Medical Care Ag & CO Kgaa (FME.D.DX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 1,500,409 | 1,742,257 | 1,751,971 | 1,838,363 | 1,623,676 |
| Income taxes - deferred | -27,213 | -72,672 | -122,149 | -41,471 | 67,259 |
| Accounts receivable | -69,061 | -73,477 | -151,844 | -46,682 | -163,197 |
| Accounts payable and accrued liabilities | 12,448 | 155,589 | 108,479 | -356,789 | -363,955 |
| Other Working Capital | 138,238 | 444,313 | 561,276 | -128,067 | -97,768 |
| Other Operating Activity | 1,126,178 | 190,134 | 481,068 | 902,025 | 1,423,483 |
| Operating Cash Flow | $2,680,999 | $2,386,144 | $2,628,801 | $2,167,379 | $2,489,498 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -898,674 | -685,255 | -668,458 | -687,783 | -829,936 |
| Net Acquisitions | 180,168 | 606,683 | 136,999 | 1,028 | -381,727 |
| Purchase Of Investment | -87,521 | -81,501 | -102,363 | -105,641 | -129,081 |
| Sale Of Investment | 83,497 | 75,134 | 89,595 | 57,671 | 144,516 |
| Investing Cash Flow | $-722,530 | $-84,939 | $-544,227 | $-734,725 | $-1,196,228 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 15,652 | -455,687 | -249,001 | -585,157 | 1,176,957 |
| Debt Issued | 1,622,553 | 61,513 | 417,877 | 986,922 | 1,244,094 |
| Debt Repayment | -1,488,623 | -1,510,975 | -1,428,032 | -1,519,772 | -2,779,954 |
| Common Stock Repurchased | -585,285 | N/A | N/A | 0 | 0 |
| Dividend Paid | -422,515 | -349,162 | -328,623 | -395,556 | -392,455 |
| Other Financing Activity | -544,989 | -314,989 | -270,750 | -103,797 | -273,024 |
| Financing Cash Flow | $-1,403,207 | $-2,569,300 | $-1,858,529 | $-1,617,360 | $-1,024,382 |
| Exchange Rate Effect | -141,477 | 26,198 | -72,607 | -23,162 | 131,228 |
| Beginning Cash Position | 1,185,328 | 1,427,225 | 1,273,787 | 1,481,655 | 1,081,539 |
| End Cash Position | 1,599,113 | 1,185,328 | 1,427,225 | 1,273,787 | 1,481,655 |
| Net Cash Flow | $555,262 | $-268,095 | $226,045 | $-184,706 | $268,888 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,680,999 | 2,386,144 | 2,628,801 | 2,167,379 | 2,489,498 |
| Capital Expenditure | -915,369 | -699,358 | -684,596 | -723,988 | -854,360 |
| Free Cash Flow | 1,765,630 | 1,686,786 | 1,944,205 | 1,443,391 | 1,635,138 |